Larry M. Robbins resigned from the CVS Health Board effective August 13, 2026, citing no disagreements with company operations. The Board appointed Teresa Heitsenrether to replace him, effective November 18, 2026. Ms. Heitsenrether currently serves as Executive Vice President and Chief Data & Analytics Officer at JPMorgan Chase & Co., bringing extensive experience in data analytics, artificial intelligence, and financial services leadership. Mr. Robbins served on the Board since 2024 and contributed to governance and financial focus during a period of transition. CVS Health operates as an integrated health solutions company providing pharmacy retail, healthcare clinics, pharmacy benefits management, and insurance products.

CVS Health Corporation reported second quarter 2026 results with total revenues increasing 7.3% year-over-year to $106.1 billion. GAAP diluted earnings per share rose to $2.31 from $0.80 in the prior year, while adjusted EPS reached $2.58 compared to $1.81. The company raised its full-year 2026 guidance, increasing the projected GAAP diluted EPS range to $6.84–$7.04 from $6.24–$6.44 and adjusting the cash flow from operations target upward to at least $11.5 billion. CVS Health operates in the healthcare services industry, providing pharmacy benefits management, retail pharmacy services, and health insurance products.

CVS Health Corporation stockholders approved the 2026 Incentive Compensation Plan and the ratification of Ernst & Young LLP as the company's independent auditor at the 2026 Annual Meeting. A stockholder proposal to reduce the threshold for the right to act by written consent was defeated, receiving 417,969,177 votes in favor and 617,361,014 votes against.

CVS Health Corporation issued a press release on May 6, 2026, announcing its financial results for the three months ended March 31, 2026.

CVS Health Corporation has elected John E. Gallina to its Board of Directors, effective March 19, 2026. Mr. Gallina, the former Executive Vice President and CFO of Elevance Health, will also serve on the company's Audit Committee as a designated audit committee financial expert.

CVS Health Corporation issued a press release on February 10, 2026, announcing its financial results for the three months and full year ended December 31, 2025. The specific financial figures and performance details are contained in the accompanying press release furnished as Exhibit 99.1.